14 may 2012 accelerate the value creation process and help the company to develop and grow
TRANSCRIPT
Bormioli Rocco S.p.A. is a manufacturer of tableware, glass containers and plastic packaging with a consolidated industrial footprint in Europe
AzuquecaTableware
St. SulpicePlastic/Pharma
MasnieresGlass/c&p
RivanazzanoPlastic/Pharma
TrezzanoGlass/F&B
BergantinoGlass/Pharma
CastelguelfoPlastic/Pharma
Altare Tableware
Fidenzatableware
Tableware
Glass pharma
Glass beverage
Plastic packaging
Glass perfumery
€227m
€106m
€65m
€87,5m
€81m
2011 sales Bormioli industrial footprint
• caps• ophthalmic caps
and droppers• syringe and spoons
• perfumery bottles• cosmetic pots
• vase• flacons• other caps• pharmaceutical
caps
• dishes• glasses• goblets
• glasses• cups• dishes• carafes
• glasses• cups and bowls• food storage• carafes• dishes
• bottles• jars
• pharma cointainers for oral products and injectables
• child proof caps• flacons• droppers
1825
Luigi Bormioli’s family opens a glasswork factory in Borgo San Donnino, near Fidenza (Parma)
In 1854 Bormioli family buys Reale Fabbrica, producing majolicas and glass, and later develops into Vetreria Bormioli Rocco
Bormioli Finanziaria strengthens its control over BRF by buying the stock owned by Groupe Danone and BPN Paribas
1854-1920
1985-1993
The company takes over the table glassware production of Saint Gobain group
1921-1972
2007
The business related to the Abbiategrasso plant is sold to Bormioli Luigi S.p.A. and the merger of Bormioli Finanziaria into BRF is completed
2011
Vision Capital, an international investment group, acquires Bormioli Group
1973-1984
In 1973, Vetreria Padana Polesana S.r.l. is acquired, together with its production plant in Bergantino
In 1969, Bormioli Metalplast S.p.A is established with the aim of providing products for the pharmaceutical, cosmetics and food sectors
Bormioli Finanziaria fully subscribes a new capital increase of BRF
2003
2001-20021997-1998
1999-2000
Bormioli Rocco & Figlio sells its 50% stake in Bormioli Luigi to the other branch of the family and purchases Fidenza Vetraria Industriale srl and Covetro S.p.A.
After the 1998-2000 crisis of the sector and due to the inefficiencies of Parma and French sites, Bormioli family decides to restructure the company
Bank loans are rescheduled, and in 2002 Bormioli Finanziaria S.p.A. acquires a shareholding in BRF (42.2%)
2005-2006
Founded in 1825 by Bormioli family, the company has over years undergone many shareholding changes and in May 2011 has been acquired by Vision Capital, an international PE fund
September 2011
May – July 2011
Due diligence in advance to acquisition
Vision Capital finalizes the acquisition
Prioritization of the key business opportunities
May 2011
Dec. 2010 – Apr. 2011
Work-streams kick-off
January 2012
Implementation launched
Top line improvement opportunities for Tableware and
Pharma BU
Bottom line initiatives to improve operational planning and asset
utilisation rates
Vision Capital conducted due diligence with the aim of identifying potential business upsides not only to assess and investigate risks. In advance of closing quickly focused on pursuing key business opportunities
Top line opportunities
Bottom line opportunities
Improvement of the asset utilisation rates
Improvement of the operational planning
process
Pharma BU Tableware BU
IMPROVEMENT
UPSIDE OPPORTUNITIES
Increase penetration in specialised retailers
Reposition the product portfolio / increase prices
Increase penetration in the US, Russian and German markets
Optimised product portfolio
Increase market penetration
Increase in type I glass (excluding Delta technology)
Entry into the tubular glass market
Glass Pharma
Plastic
Diversification into new product segments
Acquisition opportunities
On September 2011 several main work streams were defined to address both top and bottom line opportunities
Ph
ase
Mo
du
les
Ob
ject
ives
Detailed definition and development of the strategic initiatives to pursue for accelerating value, based on the options selected
Selection of the strategic options in terms of: new geographic
markets to enter key current and
prospect customers to target
optimal product mix to offer
C. Strategic plan development
C.1. Define the organic growth strategy in adjacent areas
C.2. Define a build up strategy through potential acquisitions
C.3. Develop the market entry strategy in selected countries
Develop a robust fact base analysis to define and prioritize the strategic options to pursue
A. Strategic fact base development
A.1. Product portfolio review
A.2. Assessment of selected geographic markets
A.3. Competitive landscape analysis
A.4. Customer portfolio assessment
B. Strategic objectives definition
B.1. New geographic markets prioritization
B.2. Key customer targeting
B.3. Product mix selection
Accelerate a profitable organic growth by managing the mix and developing adjacent technologies and product categories
Acquire new products, technologies, clients and enter high attractive geographic markets
Exploit the full commercial potential of existing clients
Project Polaris strategic initiatives
In October 2011 Bormioli launched “Project Polaris” to pursue the identified opportunities in the Pharma business unit
Products
Customers
New
Market opportunity identification matrix
New markets(Glass and Plastic packaging)
New products(Plastic packaging)
U.S.
India
SpainItaly
Germany
France
Russia
Puerto Rico Saudi
Arabia
China
Brazil
Customer full potential Cross – selling
Inhalation
Injection
Pharma/ Drug Delivery
Point of Care Testing
Diagnostics
Molecular Diagnostics
Laboratory Diagnostics
Existing New
Existing
Project Polaris has focused on assessing the opportunities in new markets and in adjacent product categories
Provide in-depth managerial expertise to bring extensive experience on a specific sector and to help the business excel
When necessary, conduct strategic repositioning of businesses to unlock value
Support management in developing a 100-day plan to rapidly pursue identified opportunities and:
‒ foster strategic geographical expansion in promising countries
‒ innovate product range and diversify for cross-selling and up-selling
‒ pursue build-up acquisitions to widen the companies’ dimension and leverage on operational synergies
Key take-ways in order to help businesses develop and grow